INDIVIOR PHARMACEUTICALS INC
INDVNASDAQ๐ #1328 by market capUS Equity
$36.26โฒ $0.86 (+2.43%)
Market closed ยท at closeTrack INDV
Get earnings, price moves & breaking news on Telegram
24hโฒ 2.4%
7dโ
14dโฒ 0.0%
30dโฒ 5.2%
ytdโฒ 1.1%
1yโฒ 10.8%
๐ฆMarket Cap
$4.28B
Small Cap
๐Revenue Growth (YoY)
13.6%
Healthy
๐Gross Margin
82.0%
High
๐ตFCF Margin
16.7%
Healthy
โ๏ธP/S Ratio
3.2x
Fair
Otter Score
โ
Insufficient data
Trading Snapshot
- Day Range
- $35.38 โ $36.98
- 52-Week Range
- $25.92 โ $42.81
- Volume (shares)
- 189,192
- Avg Volume (shares)
- โ
- Shares Outstanding
- 118.0M
- Next Earnings
- โ
Fundamentals Snapshot
- Annual Revenue
- $1.24B
- Last Q Revenue
- $356M
- P/E Ratio
- 12.1
- P/S Ratio
- 3.2x
- EPS (TTM)
- $2.78
- Dividend Yield
- โ
INDIVIOR PHARMACEUTICALS INC
INDVFinancial Trends
Financial history unavailable.
About INDIVIOR PHARMACEUTICALS INC
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
๐ฆฆ
Otter Score Breakdown
How it's scoredFive components, each rated 1โ5โ and equally weighted (20%), averaged to a 0โ100 score:๐ Quality โ gross margin๐ Growth โ revenue YoYโ๏ธ Valuation โ P/S ratioโก Momentum โ 30-day price change๐ง Dilution โ 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
๐Qualityโ
โ
โ
โ
โ
๐Growthโ
โ
โ
โ
โ
โ๏ธValuationโ
โ
โ
โ
โ
โกMomentumโ
โ
โ
โ
โ
Overall Score
Insufficient data
โ/100
Analyst data unavailable.
Latest News & Updates
News unavailable.